700,000 Americans live with primary brain tumors, of which 29% are malignant.
An estimated nearly 25,000 Americans will be diagnosed with malignant brain tumors in 2023.
It is estimated that nearly 19,000 will die from brain tumors in 2023.
Glioblastoma multiforme is the most common primary malignant brain tumor, accounting for about 50% of all malignant brain tumors. Median survival is 8 months.
Brain tumors are the most common solid cancer and the leading cause of cancer-related death in children age 0-14.
National Brain Tumor Society “unrelentingly invests in, mobilizes and unites the brain tumor community to discover a cure, deliver effective treatments, and advocate for patients and caregivers.” Efforts are directed toward neuro-oncology and industry research to develop new treatments and technology to find a cure, advocacy for brain tumor patients and families, expanded patient access to new treatment trials, increased survival with improved quality of life, and increased federal funding for brain tumor research.